{"id":"NCT02501629","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","briefTitle":"An Efficacy and Safety Study of Reslizumab Subcutaneous in Patients With Oral Corticosteroid Dependent Asthma and Elevated Blood Eosinophils","officialTitle":"A Phase 3, 24-Week Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy and Safety Study of Reslizumab Subcutaneous Dosing (110 mg Every 4 Weeks) in Patients With Oral Corticosteroid Dependent Asthma and Elevated Blood Eosinophils","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-09-29","primaryCompletion":"2017-06-19","completion":"2017-12-04","firstPosted":"2015-07-17","resultsPosted":"2018-09-13","lastUpdate":"2021-11-09"},"enrollment":177,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Asthma","Elevated Blood Eosinophils","Oral Corticosteroid Dependence"],"interventions":[{"type":"DRUG","name":"Reslizumab","otherNames":["CEP38072"]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Non-Oral Corticosteroid (non-OCS) Asthma Medication","otherNames":[]},{"type":"DRUG","name":"Oral Corticosteroid (OCS)","otherNames":[]}],"arms":[{"label":"Reslizumab 110 mg","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The primary objective of the study is to determine the ability of reslizumab administered by subcutaneous injection to produce a corticosteroid-sparing effect in patients with oral corticosteroid (OCS)-dependent asthma and elevated blood eosinophils, without loss of asthma control.","primaryOutcome":{"measure":"Number of Participants With Reduction In Daily Oral Corticosteroid (OCS) Dose During Weeks 20-24 As Compared to the Optimized Dose At Baseline","timeFrame":"Baseline (Day 1), Weeks 20-24","effectByArm":[{"arm":"Placebo","deltaMin":20,"sd":null},{"arm":"Reslizumab 110 mg","deltaMin":18,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.468"}]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":127,"countries":["United States","Argentina","Australia","Belgium","Czechia","France","Germany","Hungary","Israel","Italy","Mexico","Netherlands","Poland","Russia","South Korea","Spain","Ukraine"]},"refs":{"pmids":["32066536"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":89},"commonTop":["Viral upper respiratory tract infection","Bronchitis","Asthma","Upper respiratory tract infection","Hypertension"]}}